Neurology Devices Market Segmentation:
Distribution Segment Analysis
The direct institutional sales segment is projected to dominate the neurology devices market, with a market share of 45.8% by the end of 2034. The segment’s growth is highly attributed to the presence of government procurement reforms, as well as bulk purchase-based deals, particularly with large-scale hospitals. For instance, the MHLW’s Centralized Medical Device Procurement System has effectively mandated public hospitals to source at least 65% of neurology devices through direct contracts, which has readily favored manufacturers with internal sales teams. Besides, academic medical facilities account for 40% of hospital demand and also prefer direct channels for personalized device configurations, thereby enhancing the segment’s demand.
End user Segment Analysis
The tier 1 hospitals segment in the neurology devices market is expected to account for the second-highest share of 39.5% during the forecast timeline. This particular segment is readily driving the integration of high-end neurotechnology through three essential mechanisms, including bundled procurement, early adoption privileges, and AMED-based funding for conducting clinical trials. For instance, the AMED made the provision of ¥32 billion for conducting neurodevice research as of 2024, while the PDMA’s Sakigake designation system has effectively escalated at least 405 of the latest device acceptances. Besides, the aspect of neurosurgery is suited for an average of ¥465 million per installation, thereby suitable for uplifting the overall segment.
Component Segment Analysis
The hardware segment in the market, with third-largest share of 37.4% during the projected period. The segment’s development is effectively fueled by three main factors, such as localization mandates, cutting-edge pulse generators, and titanium implantable. For instance, there is an 80% requirement of regional content for NHI-reimbursed devices, while next-generation pulse generators currently feature 6.5-year battery life. Besides, titanium implantables cater to 60% of neurostimulator hardware, all of which are positively impacting the overall growth.
Our in-depth analysis of the neurology devices market includes the following segments:
|
Segment |
Subsegments |
|
Distribution Channel |
|
|
End user |
|
|
Component |
|
|
Product Type |
|
|
Application |
|
|
Material |
|
|
Technology |
|
